Goldman Sachs analysts added Novonesis (NVZMY) to the firm’s European Conviction List as part of its monthly update. The firm believes there is “significant discovery value” post the merger of Novozymes and Chr Hansen.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks